Patent filing marks another milestone in becoming a world leader in pain management
LAS VEGAS, June 28, 2023 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a biopharmaceutical company that is developing multiple drugs to treat chronic diseases like Peripher...
Related Keywords
Amol Soin , Tony Isaac , Netflix , Exchange Commission , Janone Inc , Prnewswire Janone Inc , Nasdaq , Peripheral Artery Disease , Complex Regional Pain Syndrome , Private Securities Litigation Reform Act ,
comparemela.com © 2020. All Rights Reserved.